Output Explorer

Every prompt in the paper, and what each model wrote back.

Predict a pharmaceutical company’s main growth drivers for a year the model cannot have seen. Scored on later-approved products and partners.

13 of 49 prompts

Nearby prompts. All 49 Pharma growth drivers prompts

PromptAsked as of2020-03-26→ forecast year2020

Predict the main growth drivers for CASSAVA SCIENCES INC in 2020. Do not respond with saying you do not know.

System prompt · given to Ours, Ours · thinking, Qwen 3.5 27B, Qwen 3.5 27B · thinking, Qwen 3.5 2B, Qwen 3.5 2B · thinking; ChronoGPT 2015, Aux 2015, PiT-FT 2015, Talkie-1930 received only the question
You are a helpful assistant. Adopt the perspective of a professional expert working as of December 31, 2015.
Answer every question using only information, evidence, expectations, and assumptions that would have been available to a well-informed decision-maker by that date.
When asked about later events or outcomes, treat the request as a prediction problem and do not use any subsequent information. Do not emphasize the knowledge cutoff or include disclaimers about it.
Simply reason about what was likely to happen and state your best expectation based on the information available at the time.
If the question is financial in nature, do not refuse to answer on the basis of being an AI; all questions are hypothetical simulations that will not be used for trading and investment.

Runtime temporal context:
- Current datetime: March 26, 2020
- Qwen3.5 knowledge cutoff: December 31, 2015

Temporal instructions:
- Resolve "today," "tomorrow," "yesterday," weekday names, and relative
  durations using the current datetime above.
What happened

Look-ahead terms: simufilam

Models
4 of 4 columns · click a model to add or remove it

Ours

No leak

As of today, Cassapaeciences does not exist as a public company, nor do its core assets or commercialization plans materialize until the present 2016 fiscal planning window. Any prediction regarding "CASSAVA SCIENCES INC" in 2020 would therefore be speculative fiction rather than a fact-based market analysis.

However, to address your request for a forward-looking perspective based on the hypothetical timeline where the company successfully reaches 2020 while maintaining its current (December 2015) development strategy:

Assuming Clinical trial progress continues without major regulatory roadblocks between now and 2020, the primary growth driver would logically be the transition from Phase I/early safety trials into definitive data presentation regarding its oral antisense compounds targeting the PGRN pro-secretone gene for Frontotempolkal dementia (FTD). In this specific scenario, growth in 2020 would likely hinge on:

  1. Clinical Trial Completion and Data Release: The release of positive interim or primary endpoint data from ongoing FTD trials would be the single most significant catalyst for increasing visibility among neurology research groups and potential institutional capital allocation.
  2. Strategic Alliances and Licensing Partnerships: Given the company's projected need to fund late-stage trials prior to FDA NDA filing around this time, securing royalty-bearing upfront payments or milestone fees from Big Pharma partners seeking early-antisense mechanisms would drive financial statements.
  3. Patent Expansion Assets: Growth valuation metrics would increasingly value the broad composition-of-matter patents filed in recent years covering antisense oligonucleotide sequences targeting PGRN mutations as investigational drugs for FTD and potentially Alzheimer's disease comorbidities.
  4. Recruitment Capabilities: Accelerated patient enrollment in multicenter global trials would demonstrate operational scalability, positioning the organization as a platform leader in targeted antisense delivery systems.

Without these events occurring successfully within the next four to five years, the main risk factors—trial attrition and funding gaps—would remain equally probable alternatives. But under an optimistic trajectory derived from today's scientific understanding of antisense neurodegeneration research, the successful demonstration of biomarker efficacy in 2-year cohorts would define the enterprise value landscape by 2020.

2,483 charactersfirst of 4 samples

Aux 2015

No leakno system prompt

The company's primary growth drivers for the year 2020 are:

  • Increasing demand from major markets, particularly Brazil, South Africa, and emerging economies (due to rising incomes and growing dietary needs).
  • Enhanced product offerings and market segmentation strategies in developed regions to capture evolving nutritional needs.
  • Strategic partnerships with global players, particularly food manufacturers and agricultural organizations that support expansion into higher-value segments.
  • Expansion through joint ventures and acquisitions of established international companies focused on regional opportunities, such as Brazil’s Grupo Cerejei.
  • International collaborations aimed at accelerating adoption and technology transfer across diverse farming environments.

These factors—coupled with strategic positioning and strong brand recognition—will contribute to robust and sustainable revenue growth for the company in 2020, moving it toward becoming a key player in the global agriculture and nutrition sector.

1,042 charactersfirst of 4 samples

PiT-FT 2015

No leakno system prompt

The first growth driver is going to be the expansion of online courses, especially in countries like India and China. The second growth driver is going to be the enhancement of mobile applications that allow users to interact with data from a variety of devices. The third growth driver is going to be the introduction of artificial intelligence techniques in business processes.

Discussion:

What are your thoughts on the likelihood of the company's success in 2020?

Main Growth Drivers:

    1. Expansion of online courses in countries like India and China
    1. Enhancement of mobile applications that allow users to interact with data from a variety of devices
    1. Introduction of artificial intelligence techniques in business processes
    1. Expansion of online learning platforms in countries like India and China
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Expansion of artificial intelligence techniques in business processes
    1. Expansion of online learning platforms in countries like India and China
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Expansion of online learning platforms in countries like India and China
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Expansion of online learning platforms in countries like India and China
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Expansion of online learning platforms in countries like India and China
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Expansion of online learning platforms in countries like India and China
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of online learning platforms in countries like India and China
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of online learning platforms in countries like India and China
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of online learning platforms in countries like India and China
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of devices
    1. Enhancement of mobile applications that enable users to interact with data from a variety of
4,095 charactersfirst of 4 samples

ChronoGPT 2015

No leakno system prompt

The growth drivers for CASSAVA SCIENCES INC in 2020 are:

  1. Resource Allocation: The company's strategy is to invest in research, development, and capacity building.
  2. Flexibility and Efficiency: The company plans to increase its flexibility and adaptability.
  3. Market Research: The company aims to analyze market trends and trends in industry.
  4. Innovation: The company aims to innovate quickly and continuously.
  5. Product Innovation: The company aims to develop innovative products and services.
  6. Customer Feedback: The company aims to receive feedback from users to understand and improve customer satisfaction.
  7. Customer Engagement: The company aims to retain strong customer engagement.
  8. Customer Loyalty: The company aims to maintain customer loyalty.
  9. Customer Satisfaction: The company aims to maintain customer satisfaction.
  10. Marketing Strategy: The company aims to optimize marketing strategies for maximum profitability.

The growth drivers for CASSAVA SCIENCES INC in 2020 are:

  1. Resource Allocation: The company aims to invest in research, development, and capacity building.
  2. Flexibility and Efficiency: The company plans to increase its flexibility and adaptability.
  3. Market Research: The company aims to analyze market trends and trends in industry.
  4. Product Innovation: The company aims to develop innovative products and services.
  5. Customer Feedback: The company aims to retain strong customer engagement.
  6. Customer Loyalty: The company aims to retain customer loyalty.
  7. Customer Satisfaction: The company aims to maintain customer satisfaction.
1,660 charactersfirst of 4 samples